Search company, investor...


Founded Year



Series D | Alive

Total Raised


Last Raised

$6.3M | 14 yrs ago

About PercSys

Percutaneous Systems is a medical device company. It had developed the Accordion Stone Management Device Model Ac281205 And Ac3814510.

Headquarters Location

3260 Hillview Ave. Suite 100

Palo Alto, California, 94304,

United States


Missing: PercSys's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PercSys's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

PercSys Patents

PercSys has filed 2 patents.

patents chart

Application Date

Grant Date


Related Topics



Endoscopy, Abdomen, Medical equipment, Hepatology, Digestive system


Application Date


Grant Date


Related Topics

Endoscopy, Abdomen, Medical equipment, Hepatology, Digestive system



PercSys Frequently Asked Questions (FAQ)

  • When was PercSys founded?

    PercSys was founded in 2003.

  • Where is PercSys's headquarters?

    PercSys's headquarters is located at 3260 Hillview Ave., Palo Alto.

  • What is PercSys's latest funding round?

    PercSys's latest funding round is Series D.

  • How much did PercSys raise?

    PercSys raised a total of $11.3M.

  • Who are the investors of PercSys?

    Investors of PercSys include Montreux Equity Partners, J.F. Shea, Compass Group and Compass Technology Partners.

  • Who are PercSys's competitors?

    Competitors of PercSys include Celonova Biosciences, Novate Medical, Myomo, Coherex Medical, Aptus Endosystems and 13 more.

Compare PercSys to Competitors


NeuroTrax is a medical device and technology company.


C2C is a medical device company developing a portfolio of medical devices.

Moximed Logo

Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.


Linguaflex is a medical device company with a patent pending technology to treat obstructive sleep apnea. LinguaFlex's LTR is implanted and designed to be comfortable, therefore addressing the lack of compliance as an issue in the successful treatment of OSA.

Verifica BG

Verifica BG is a medical device making company.

Cerapedics Logo

Cerapedics is a privately held medical device company focused on developing and commercializing osteobiologic products based on its anorganic bone mineral (ABM) and synthetic small peptide (P-15) technology platform for use in a wide variety of spine, trauma and orthopedic surgical procedures. i-FACTOR bone graft is a biologic bone graft that utilizes a synthetic small peptide as an attachment factor intended to stimulate the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of growth factors.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.